Telomir Pharmaceuticals, Inc | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases Telomir Pharmaceuticals, Inc

Home
Companies
Telomir Pharmaceuticals, Inc

BRIEF

published on 09/26/2024 at 22:05, 1 month 24 days ago

Telomir Pharmaceuticals' Dr. Michael Roizen to Discuss Longevity on Fox Business

Telomir-1 Longevity Science Telomir Pharmaceuticals Dr. Michael Roizen Telomeres
PRESS RELEASE

published on 09/26/2024 at 22:00, 1 month 24 days ago

Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
Telomir Pharmaceuticals to feature on Health Uncensored with Dr. Drew on Fox Business Network, discussing Telomir-1 and longevity science

Longevity Science Telomir Pharmaceuticals Health Uncensored Dr. Drew Telomere
BRIEF

published on 09/04/2024 at 13:35, 2 months 16 days ago

Telomir Pharmaceuticals Appoints New Chief Scientific Advisor

Clinical Trials Telomir-1 Telomir Pharmaceuticals Dr. Itzchak Angel Aging Research
PRESS RELEASE

published on 09/04/2024 at 13:30, 2 months 16 days ago

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
Telomir Pharmaceuticals, Inc. appoints Dr. Itzchak Angel as Chief Scientific Advisor to lead developments in longevity science and advance Telomir-1 small molecule for age-related conditions in humans and animals

Telomir-1 Longevity Science Telomir Pharmaceuticals Dr. Itzchak Angel Age-related Conditions
BRIEF

published on 08/20/2024 at 13:35, 3 months ago

Telomir Pharmaceuticals' Age Reversal Pill Shows Promising Results in Senior Dogs

Telomir-1 Age Reversal Longevity Science Senior Dogs Health Improvements
PRESS RELEASE

published on 08/20/2024 at 13:30, 3 months ago

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Telomir-1, a small molecule by Telomir Pharmaceuticals, shows promising results in promoting life quality and longevity in senior dogs. The pre-clinical-stage company's research aims to lead developments in longevity science through the treatment of age-related conditions

Telomir-1 Age Reversal Longevity Science Senior Dogs Pre-clinical Stage

Accesswire

Published on 11/21/2024 at 10:03, 45 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 48 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 48 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 13 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 23 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 18 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 43 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 46 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 48 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 48 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 50 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 28 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 3 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 3 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE